Beta
Login / Sign Up
Latest News
Earnings
Earning Calendar
Analyst Rating
Pricing
Novo Nordisk (NVO): Goldman Sachs maintains Neutral, PT raised to $47 from $41
NVO
Novo Nordisk
•
Goldman Sachs
•
Jun 03, 2026
0
Share